Hirabayashi K - Search Results

1

[Phase II study of carboplatin in ovarian cancer].

Kato T, Nishimura H, Yamabe T, Terashima Y, Kasamatsu T, Hirabayashi K, Nishiya I, Yajima A, Takamizawa H, Tsutsui F, et al. Kato T, et al. Among authors: hirabayashi k. Gan To Kagaku Ryoho. 1988 Aug;15(8):2291-6. Gan To Kagaku Ryoho. 1988. PMID: 3044275 Japanese.

2

[Phase III study of carboplatin in ovarian cancer].

Kato T, Nishimura H, Yamabe T, Terashima Y, Kasamatsu T, Hirabayashi K, Nishiya I, Yajima A, Takamizawa H, Tsutsui F, et al. Kato T, et al. Among authors: hirabayashi k. Gan To Kagaku Ryoho. 1988 Aug;15(8):2297-304. Gan To Kagaku Ryoho. 1988. PMID: 3044276 Japanese.

3

[Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].

Noda K, Hirabayashi K, Terashima Y, Ozaki M, Yakushiji M, Hatae M, Kanazawa K. Noda K, et al. Among authors: hirabayashi k. Gan To Kagaku Ryoho. 1997 Aug;24(10):1285-93. Gan To Kagaku Ryoho. 1997. PMID: 9279348 Clinical Trial. Japanese.

4

[Ovarian cancer].

Hirabayashi K. Hirabayashi K. Gan To Kagaku Ryoho. 1994 Mar;21(4):452-8. Gan To Kagaku Ryoho. 1994. PMID: 8129385 Review. Japanese.

5

[Treatment of advanced ovarian cancer].

Hirabayashi K. Hirabayashi K. Gan To Kagaku Ryoho. 1990 Sep;17(9):1856-63. Gan To Kagaku Ryoho. 1990. PMID: 2203316 Review. Japanese.

6

[Phase II clinical study of RP56976 (docetaxel) in patients with carcinoma ovarii or carcinoma colli uteri].

Noda K, Terajima Y, Ogita Y, Kono I, Hirabayashi K, Yakushiji M, Taguchi T. Noda K, et al. Among authors: hirabayashi k. Gan To Kagaku Ryoho. 1994 Oct;21(14):2471-7. Gan To Kagaku Ryoho. 1994. PMID: 7944493 Clinical Trial. Japanese.

7

Phase II dose escalation: a novel approach to balancing efficacy and toxicity of anticancer agents. Japanese Docetaxel Ovarian Cancer Study Group.

Fujiwara K, Kohno I, Tanaka K, Ogita S, Sasaki Y, Hirabayashi K, Yakushiji M, Tsunematsu R, Terashima Y, Taguchi T, Ohashi Y, Noda K. Fujiwara K, et al. Among authors: hirabayashi k. Anticancer Res. 1999 Jan-Feb;19(1B):639-44. Anticancer Res. 1999. PMID: 10216469 Clinical Trial.

8

[An early phase II clinical study of YM 294 (rhlL-11) in patients with solid tumors and malignant lymphoma].

Hatae M, Ariyoshi Y, Fukuoka M, Furuse K, Noda K, Hirabayashi K, Yakushiji M, Ogawa M, Takaku F. Hatae M, et al. Among authors: hirabayashi k. Gan To Kagaku Ryoho. 2005 Apr;32(4):489-96. Gan To Kagaku Ryoho. 2005. PMID: 15853215 Clinical Trial. Japanese.

9

[A clinical study of YM 294 (rhlL-11) in patients with gynecologic cancer].

Hatae M, Noda K, Yamamoto K, Ozaki M, Hirabayashi K, Nishida T, Ohashi Y, Ogawa M, Takaku F. Hatae M, et al. Among authors: hirabayashi k. Gan To Kagaku Ryoho. 2005 Apr;32(4):479-87. Gan To Kagaku Ryoho. 2005. PMID: 15853214 Clinical Trial. Japanese.

10

[An early phase II study of gemcitabine hydrochloride (LY 188011). Gemcitabine Cooperative Study Group for Early Phase II].

Fukuoka M, Noda K, Hasegawa K, Nakajima H, Furuse K, Hirabayashi K, Hasegawa K, Ogura T, Niitani H, Taguchi T. Fukuoka M, et al. Among authors: hirabayashi k. Gan To Kagaku Ryoho. 1996 Nov;23(13):1813-24. Gan To Kagaku Ryoho. 1996. PMID: 8937492 Clinical Trial. Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

721 results

Search Page

Filters